Avicanna Announces USPTO Issuance of Patent SEDDS Technology
Author of the article:
Article content
Patent No. US 11,998,632 B2 (Patent) covers Avicannas self-emulsifying drug delivery system (SEDDS) oral cannabinoid composition and methods of treating neuro…